Artwork

Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

GLP-1 and Blindness

26:58
 
Share
 

Manage episode 487940984 series 49299
Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
photo of intermediate macular degeneration c National Institutes of Health

We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness. The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration. The scientists we talk with today are Marko Popovic and Reut Shor. We also refer to a different, unrelated study, underway, to evaluate a ketogenic diet and eye health, specifically, whether or not a ketogenic diet can reduce diabetes while providing better protection to the eye.

Executive Producer: Joel Parker
Show Producer: Shelley Schlender

  continue reading

728 episodes

Artwork

GLP-1 and Blindness

KGNU - How On Earth

17 subscribers

published

iconShare
 
Manage episode 487940984 series 49299
Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
photo of intermediate macular degeneration c National Institutes of Health

We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness. The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration. The scientists we talk with today are Marko Popovic and Reut Shor. We also refer to a different, unrelated study, underway, to evaluate a ketogenic diet and eye health, specifically, whether or not a ketogenic diet can reduce diabetes while providing better protection to the eye.

Executive Producer: Joel Parker
Show Producer: Shelley Schlender

  continue reading

728 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play